Statistics for Vertex Pharmaceuticals (id:7070 VRTX)

Valuation metrics

Market cap

115.98B

Enterprise value

111.45B

Trailing P/E (ttm)

32.82

Forward P/E

23.99

PEG ratio

23.99

Price/Sales (ttm)

10.92

Price/Book (mrq)

7.43

Enterprise Value/Revenue

10.49

Enterprise Value/EBITDA

25.06

Overview

Shares outstanding

257.53M

Float

256.75M

Shares short

4.50M

% Held by insiders

0.00%

% Held by institutions

0.96%

Average volume (10 days)

1.50M

Average volume (90 days)

Price summary

52-Week low

346.29

52-Week high

519.88

52-Week change

22.34%

Beta

0.39

50-Day moving average

475.38

200-Day moving average

454.05

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

August 24th, 2000

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-4.51%

Operating margin

40.82%

Operational effectiveness

Return on assets

12.05%

Return on equity

-2.98%

Income statement

Revenue (ttm)

41.18

Revenue per share (ttm)

41.18

Quarterly revenue growth (yoy)

0.01

Gross profit (ttm)

8.61B

EBITDA

5.03B

Net income to common (ttm)

-479,800,000.00

Diluted EPS (ttm)

-1.90

Quarterly earnings growth (yoy)

1.00%

Balance sheet

Total cash (mrq)

6.52B

Total cash per share (mrq)

25.34

Total debt (mrq)

1.77B

Total Debt/Equity (mrq)

11.35

Current ratio (mrq)

246.80%

Book value per share (mrq)

60.65

Cash flow

Cash flow statement

-842,600,000.00

Levered free cash flow (LFCF)

3.06B